Due to the limited spatial resolution and partial volume effects of positron emission tomography (PET), and, to a lesser extent, of Magnetic Resonance Imaging (MRI), most tissue regions studied with these imaging modalities are heterogeneous with respect to the physiological and/or biochemical processes being examined and with respect to the concentra- tions of the relevant labeled compounds in the tissue. Most quantitative work up to now has made the simplifying assumption that the tissues are homogeneous; this has led not only to inaccurate quantification, but also to serious misinterpretations of results in some studies. We have studied the effects of tissue heterogeneity on determination of local cerebral glucose utilization and local cerebral blood flow. Mathematical models to describe the kinetics of deoxyglucose or fluorodeoxyglucose uptake and metabolism in heterogeneous tissues were developed and vali- dated in simulation, animal, and human studies. The most appropriate kinetic model and optimal experimental protocol for the measurement of cerebral glucose utilization in man with [18F]fluorodeoxyglucose and PET were identified. Additional tools are being developed for the analysis of time-series data from tracer studies. These tools will facilitate the construction of kinetic models of new tracers and the extension of mathematical models of currently used tracers to additional physiological and pathophysiological conditions. We have optimized and established the properties of a new spectral analysis technique that differs from conventional analyses in that it does not rely on the a priori postulation of a kinetic model nor on the assumption of tissue homogeneity. We are currently applying the spectral analysis technique to multiexponential models, e.g. those for clearance of labeled molecules from the plasma, and to the problem of identifying the kinetic properties of gadolinium-diethylenetriaminepenta- acetic acid (Gd-DTPA), a paramagnetic contrast agent used in MRI studies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Intramural Research (Z01)
Project #
1Z01MH002569-03
Application #
3781456
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1993
Total Cost
Indirect Cost
Name
U.S. National Institute of Mental Health
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Bishu, Shrinivas; Schmidt, Kathleen C; Burlin, Thomas et al. (2008) Regional rates of cerebral protein synthesis measured with L-[1-11C]leucine and PET in conscious, young adult men: normal values, variability, and reproducibility. J Cereb Blood Flow Metab 28:1502-13
Tokugawa, Joji; Ravasi, Laura; Nakayama, Toshiyuki et al. (2007) Operational lumped constant for FDG in normal adult male rats. J Nucl Med 48:94-9
Tokugawa, Joji; Ravasi, Laura; Nakayama, Toshiyuki et al. (2007) Distribution of the 5-HT(1A) receptor antagonist [ (18)F]FPWAY in blood and brain of the rat with and without isoflurane anesthesia. Eur J Nucl Med Mol Imaging 34:259-66
Smith, Carolyn Beebe; Schmidt, Kathleen C; Qin, Mei et al. (2005) Measurement of regional rates of cerebral protein synthesis with L-[1-11C]leucine and PET with correction for recycling of tissue amino acids: II. Validation in rhesus monkeys. J Cereb Blood Flow Metab 25:629-40
Schmidt, Kathleen C; Cook, Michelle P; Qin, Mei et al. (2005) Measurement of regional rates of cerebral protein synthesis with L-[1-11C]leucine and PET with correction for recycling of tissue amino acids: I. Kinetic modeling approach. J Cereb Blood Flow Metab 25:617-28
Schmidt, Kathleen C; Smith, Carolyn Beebe (2005) Resolution, sensitivity and precision with autoradiography and small animal positron emission tomography: implications for functional brain imaging in animal research. Nucl Med Biol 32:719-25
Shimoji, Kazuaki; Ravasi, Laura; Schmidt, Kathleen et al. (2004) Measurement of cerebral glucose metabolic rates in the anesthetized rat by dynamic scanning with 18F-FDG, the ATLAS small animal PET scanner, and arterial blood sampling. J Nucl Med 45:665-72
Shimoji, Kazuaki; Esaki, Takanori; Itoh, Yoshiaki et al. (2003) Inhibition of [18F]FP-TZTP binding by loading doses of muscarinic agonists P-TZTP or FP-TZTP in vivo is not due to agonist-induced reduction in cerebral blood flow. Synapse 50:151-63
Turkheimer, F; Pettigrew, K; Sokoloff, L et al. (2000) Selection of an adaptive test statistic for use with multiple comparison analyses of neuroimaging data. Neuroimage 12:219-29
Schmidt, K (1999) Which linear compartmental systems can be analyzed by spectral analysis of PET output data summed over all compartments? J Cereb Blood Flow Metab 19:560-9

Showing the most recent 10 out of 11 publications